4
Changes in Ownership
Trevi Therapeutics, Inc. Filed Acc 0001209191-22-040287
Options or other derivatives
- Chief Development Officer acquired 48,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Forbes William P Chief Development Officer | 2022-06-29 | Grant or award · Performance Stock Options (right to buy) | +48,000 | 48,000 | D: show line 1 in the form |
Loading xslF345X03/doc4.xml…